JM
John L McManus
President and CEO

John L McManus insider trades: Aeolus Pharmaceuticals (AOLS) stock buys and sales

President and CEO, Aeolus Pharmaceuticals Last trade Mar 6, 2013 38 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
17
Open-market trades
since 2005
1
Company
last trade 2013

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where John reports to the SEC

Open-market buys and sales

17 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 6, 2013AOLS↑ Buy$4K
May 24, 2011AOLS↑ Buy$5K
May 18, 2011AOLS↑ Buy$4K
May 18, 2011AOLS↑ Buy$4K
Mar 15, 2011AOLS↑ Buy$7K
Apr 15, 2010AOLS↑ Buy$4K
Oct 1, 2008AOLS↓ Sell$8K
Oct 1, 2008AOLS↑ Buy$8K
Jul 30, 2007AOLS↑ Buy$3K
Jul 19, 2006AOLS↑ Buy$750
Mar 21, 2006AOLS↑ Buy$4K
Dec 30, 2005AOLS↑ Buy$950
Sep 22, 2005AOLS↑ Buy$3K
Aug 23, 2005AOLS↑ Buy$455
Aug 10, 2005AOLS↑ Buy$4K
Jul 21, 2005AOLS↑ Buy$970
Jul 8, 2005AOLS↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About John L McManus's insider trades

John L McManus is President and CEO at Aeolus Pharmaceuticals (AOLS). Since Jul 8, 2005, John has reported 16 open-market purchases worth $62K and 1 sale worth $8K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (24 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AOLS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.